biospecimen__admin__batch_number	231.65.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	61CA051E-ADBD-418A-9C59-51FFFE2F5105
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-G3-A3CH-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-G3-A3CH-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-G3-A3CH-01A
biospecimen__bio__biospecimen_barcode_bottom	0118957432
biospecimen__bio__day_of_creation	11
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	10
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-G3-A3CH.735AAE4A-21E1-4481-9D86-385CCE5712D1.pdf
biospecimen__bio__plate_column	8
biospecimen__bio__plate_id	A22J
biospecimen__bio__plate_row	A
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2012
biospecimen__shared__bcr_patient_barcode	TCGA-G3-A3CH
biospecimen__shared__patient_id	A3CH
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	36CDA441-B365-4F6C-9B4F-80726AFF986B
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	0.3
clinical__chol_lihc_shared__albumin_result_specified_value	0.3
clinical__chol_lihc_shared__albumin_result_upper_limit	0.5
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.7
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.9
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	10
clinical__chol_lihc_shared__fetoprotein_outcome_value	41
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.1
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1.2
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.4
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	53
clinical__clin_shared__bcr_followup_barcode	TCGA-G3-A3CH-F40093
clinical__clin_shared__bcr_followup_uuid	70FB1925-4E06-4CD1-B9D5-A1E3001732B5
clinical__clin_shared__day_of_form_completion	12
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	1
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	142
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2012
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2010
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Severe
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	No
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	NO
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_additional_surgery_procedure	431
clinical__nte__days_to_new_tumor_event_after_initial_treatment	558
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	YES
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rx__bcr_drug_barcode	TCGA-G3-A3CH-D40096
clinical__rx__bcr_drug_uuid	DC72364F-DDFD-4B54-9477-F29E3142536B
clinical__rx__days_to_drug_therapy_start	717
clinical__rx__drug_name	Sorafenib
clinical__rx__therapy_ongoing	YES
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T3a
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	ce7f87cc-15b9-449e-ba65-06860e6012aa
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-G3-A3CH-01A-11R-A22J-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	32e0c47b-1434-482f-b737-d24432c12339
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.8
gdc__analytes__analyte_id	d8c65046-6003-4bab-ae58-f28ee06a50aa
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	3a2d7482-c246-411e-841f-71d96e353328
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:44:50.676868-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	49ab2865-f2f4-5d68-9240-f2e12b628c26
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1957
gdc__diagnoses__age_at_diagnosis	19473
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-19473.0
gdc__diagnoses__days_to_last_follow_up	780.0
gdc__diagnoses__diagnosis_id	0048391f-a4d5-5c21-8c16-a43e85567785
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiia
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	23.355636914530994
gdc__exposures__exposure_id	b3520b5e-7eb7-52e7-9d50-157758e410f3
gdc__exposures__height	178.0
gdc__exposures__weight	74.0
gdc__file_id	097683f7-5d91-4107-a5b7-1e5ffc2039b7
gdc__file_name	802d73fc-b3e8-4eb0-ae3e-16db43c7c207.mirbase21.mirnas.quantification.txt
gdc__file_size	50383
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	78c6b6cf4ec90052c9dce1fba481257e
gdc__portions__is_ffpe	false
gdc__portions__portion_id	d28528a8-684f-42e6-b642-65a669ef2626
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	296
gdc__samples__initial_weight	120.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	735AAE4A-21E1-4481-9D86-385CCE5712D1
gdc__samples__sample_id	4621932d-aa60-4886-8ed4-3a34edd8baf4
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	96.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	ea09fcb6-6c1d-4f1a-bade-c7d51a3b4cee
gdc__submitter_id	mirna_swap_dr11_338_MirnaExpressionbd77f6b4-db3a-47b9-98a2-29b1170fac9f_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	G3
gdc__tissue_source_site__name	Alberta Health Services
gdc__tissue_source_site__tissue_source_site_id	addd7b04-91a3-5179-99a5-cbff20df6bb4
gdc__treatments__treatment_id	56bd90cc-9bfb-57fc-8950-e858523aabb7
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:11:12.671+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/ce7f87cc-15b9-449e-ba65-06860e6012aa-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/ce7f87cc-15b9-449e-ba65-06860e6012aa-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129754
manually_curated__local_md5	4e6869e737232bdbaa2903da9141b2f7
manually_curated__opengdc_download_date	2018-10-16T17:13:00.000158+02:00
manually_curated__opengdc_file_md5	34b9df4ec0727182331287c7c0bc3679
manually_curated__opengdc_file_size	50382
manually_curated__opengdc_id	ce7f87cc-15b9-449e-ba65-06860e6012aa-meq
manually_curated__origin_file_size	129754
manually_curated__origin_last_modified_date	Tue Oct 16 17:57:00 CEST 2018
manually_curated__origin_md5	4e6869e737232bdbaa2903da9141b2f7
manually_curated__tissue_status	tumoral
